Therefore, we could assume that CR disorders may alter the GM with subsequent disruption of the HDAC3 pathway, thereby contributing to explaining obesity and T2DM in patients with circadian sleep alterations [87]. The gene discussed is HDAC3; the disease is obesity disorder.